Author Correction: A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics
Michael A. Crone,
Miles Priestman,
Marta Ciechonska,
Kirsten Jensen,
David J. Sharp,
Arthi Anand,
Paul Randell,
Marko Storch and
Paul S. Freemont ()
Additional contact information
Michael A. Crone: London Biofoundry, Imperial College Translation and Innovation Hub, White City Campus
Miles Priestman: London Biofoundry, Imperial College Translation and Innovation Hub, White City Campus
Marta Ciechonska: London Biofoundry, Imperial College Translation and Innovation Hub, White City Campus
Kirsten Jensen: London Biofoundry, Imperial College Translation and Innovation Hub, White City Campus
David J. Sharp: Imperial College London
Arthi Anand: North West London Pathology
Paul Randell: North West London Pathology
Marko Storch: London Biofoundry, Imperial College Translation and Innovation Hub, White City Campus
Paul S. Freemont: London Biofoundry, Imperial College Translation and Innovation Hub, White City Campus
Nature Communications, 2020, vol. 11, issue 1, 1-1
Abstract:
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Date: 2020
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-020-18720-1 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-18720-1
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-020-18720-1
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().